54 Result(s)

Article

Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study

Allogeneic haematopoietic cell transplantation (alloHCT) has curative potential counterbalanced by its toxicity. Prognostic scores fail to include current era patients and alternative donors. We examined adult...

A. Mussetti, B. Rius-Sansalvador, V. Moreno, C. Peczynski… in Bone Marrow Transplantation (2024)

Article

Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis

We performed a retrospective assessment of patient- and transplant-specific characteristics and outcomes for 4142 patients undergoing allogeneic haematopoietic cell transplant for myelofibrosis between 1995 an...

D. McLornan, D. J. Eikema, T. Czerw, N. Kröger, L. Koster… in Bone Marrow Transplantation (2021)

Article

Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide

Therapy-related acute promyelocytic leukemia (t-APL) is relatively rare, with limited data on outcome after treatment with arsenic trioxide (ATO) compared to standard intensive chemotherapy (CTX). We evaluated...

S Kayser, J Krzykalla, M A Elliott, K Norsworthy, P Gonzales, R K Hills… in Leukemia (2017)

Article

Evolution of NPM1-negative therapy-related myelodysplastic syndromes following curative treatment of NPM1-mutant AML

S Herold, K Sockel, C Sayehli, R Herbst, U Dührsen, U Oelschlägel, A Böttner… in Leukemia (2017)

Article

Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipient

S Herold, M Kuhn, M v Bonin, T Stange, U Platzbecker, J Radke, T Lange… in Leukemia (2017)

Article

Myelodysplastic syndromes and bone loss in mice and men

H Weidner, M Rauner, F Trautmann, J Schmitt, E Balaian, A Mies, S Helas… in Leukemia (2017)

Article

Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis

Myeloproliferative neoplasm (MPN)-associated myelofibrosis is a MPN characterized by bone marrow fibrosis, cytopenias, splenomegaly and constitutional symptoms. Pomalidomide, an immune-modifying drug, is repor...

R F Schlenk, F Stegelmann, A Reiter, E Jost, N Gattermann, H Hebart, C Waller… in Leukemia (2017)

Article

Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)

M Mossner, J-C Jann, D Nowak, U Platzbecker, A Giagounidis, K Götze, A Letsch… in Leukemia (2016)

Article

Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)

E Schuler, A Giagounidis, D Haase, K Shirneshan, G Büsche, U Platzbecker… in Leukemia (2016)

Article

Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantation

Ibrutinib, a recently approved inhibitor of Bruton’s tyrosine kinase (BTK), has shown great efficacy in patients with high-risk CLL. Nevertheless, there are few data regarding its use in patients who relapsed ...

C S Link, R Teipel, F Heidenreich, E Rücker-Braun… in Bone Marrow Transplantation (2016)

Article

Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial

In patients with relapsed or refractory (r/r) acute myeloid leukemia (AML), long-term disease control can only be achieved by allogeneic hematopoietic stem cell transplantation (HSCT). We studied the safety an...

J M Middeke, R Herbst, S Parmentier, G Bug, M Hänel, G Stuhler… in Leukemia (2016)

Article

Efficacy and safety of deferasirox in non-thalassemic patients with elevated ferritin levels after allogeneic hematopoietic stem cell transplantation

Elevated serum ferritin contributes to treatment-related morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). The multicenter DE02 trial assessed the safety, efficacy and im...

N Jaekel, K Lieder, S Albrecht, O Leismann, K Hubert, G Bug… in Bone Marrow Transplantation (2016)

Article

Frequency and prognostic impact of casein kinase 1A1 mutations in MDS patients with deletion of chromosome 5q

M Heuser, M Meggendorfer, M M A Cruz, J Fabisch, S Klesse, L Köhler, G Göhring… in Leukemia (2015)

Article

Which prognostic score in MDS? Both!

U Platzbecker in Leukemia (2015)